Please assess the completion status of the following clinical trial:

Trial Title: Catheter Thrombectomy in Patients With Massive Pulmonary Embolism

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients \>= 18 years of age with pulmonary embolism and cardiogenic shock, defined as a systolic arterial pressure \<= 90 mmHg, a drop in systolic arterial pressure \>= 40 mmHg for \>= 15 minutes, or ongoing administration of catecholamines for systemic arterial hypotension~2. Subtotal or total filling defect in the left and/or right main pulmonary artery due to massive PE, as assessed by chest computed tomography or by conventional pulmonary angiography~3. Right ventricular dysfunction on echocardiography: RV systolic hypokinesis and/or RV dilation (optional)~4. Failed thrombolysis or at least one of the following contraindications to PE thrombolysis present:~   * Active bleeding~  * History of intracranial bleeding~  * Surgery, delivery, organ biopsy, puncture of a non-compressible vessel within 10 days~  * History of stroke~  * Gastrointestinal bleeding within 10 days~  * Significant trauma within 15 days~  * Head injury requiring hospitalization within 1 year~  * Active cancer with known hemorrhagic risk~  * Neurosurgery or ophthalmologic surgery within the past year~  * Platelets \< 50,000 or INR \>2.0~  * Pregnancy~Exclusion Criteria~1. Systemic (paradoxical) embolism in the presence of an atrial septal defect or patent foramen ovale~2. Free floating right heart thrombi, left heart thrombi~3. Life expectancy due to underlying disease less than one month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).